Davita - Hilliard Station Dialysis in Hilliard, Ohio - Dialysis Center

Davita - Hilliard Station Dialysis is a medicare approved dialysis facility center in Hilliard, Ohio and it has 13 dialysis stations. It is located in Franklin county at 2447 Hilliard Rome Road, Hilliard, OH, 43026. You can reach out to the office of Davita - Hilliard Station Dialysis at (614) 876-3610. This dialysis clinic is managed and/or owned by Davita. Davita - Hilliard Station Dialysis has the following ownership type - Profit. It was first certified by medicare in March, 2014. The medicare id for this facility is 362808 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameDavita - Hilliard Station Dialysis
Location2447 Hilliard Rome Road, Hilliard, Ohio
No. of Dialysis Stations 13
Medicare ID362808
Managed ByDavita
Ownership TypeProfit
Late Shifts No

Contact Information


2447 Hilliard Rome Road, Hilliard, Ohio, 43026
(614) 876-3610

News Archive

Lawmakers, though still elbowing, agree on some health care reforms

Lost in the debate over key issues is the fact that lawmakers working on health care reform agree on major parts of reform, The Los Angeles Times reports.

New report analyzes Mobile Medical Apps market worldwide

Global Information Inc. announces the addition of a new market research report "Mobile Medical Apps Trends" at GIIResearch.com

Researchers seek to develop novel antibody to treat glioblastoma

Scientists of Helmholtz Zentrum München and the Munich University Hospital are developing a novel antibody to treat brain tumors.

TUM scientists uncover novel mechanisms of action for skin disease medication

Imiquimod is a medication successfully used in the treatment of skin diseases. In addition to its known mechanism of action, it also triggers other processes in the body.

Scientists have captured on video the intracellular version of a postal delivery service

Reporting in the journal Biochemical and Biophysical Research Communications (BBRC), bioengineering researchers at UC San Diego published videos of a key message-carrying protein called paxillin moving abruptly from hubs of communication and transportation activity on the cell surface toward the nucleus.

Read more Medical News

› Verified 3 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Davita - Hilliard Station Dialysis from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1003251679
Organization NameHilliard Station Dialysis
Doing Business AsHeyburn Dialysis Llc
Address2447 Hilliard Rome Rd Hilliard, Ohio, 43026
Phone Number(615) 341-6311

News Archive

Lawmakers, though still elbowing, agree on some health care reforms

Lost in the debate over key issues is the fact that lawmakers working on health care reform agree on major parts of reform, The Los Angeles Times reports.

New report analyzes Mobile Medical Apps market worldwide

Global Information Inc. announces the addition of a new market research report "Mobile Medical Apps Trends" at GIIResearch.com

Researchers seek to develop novel antibody to treat glioblastoma

Scientists of Helmholtz Zentrum München and the Munich University Hospital are developing a novel antibody to treat brain tumors.

TUM scientists uncover novel mechanisms of action for skin disease medication

Imiquimod is a medication successfully used in the treatment of skin diseases. In addition to its known mechanism of action, it also triggers other processes in the body.

Scientists have captured on video the intracellular version of a postal delivery service

Reporting in the journal Biochemical and Biophysical Research Communications (BBRC), bioengineering researchers at UC San Diego published videos of a key message-carrying protein called paxillin moving abruptly from hubs of communication and transportation activity on the cell surface toward the nucleus.

Read more Medical News

› Verified 3 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data17
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL35

News Archive

Lawmakers, though still elbowing, agree on some health care reforms

Lost in the debate over key issues is the fact that lawmakers working on health care reform agree on major parts of reform, The Los Angeles Times reports.

New report analyzes Mobile Medical Apps market worldwide

Global Information Inc. announces the addition of a new market research report "Mobile Medical Apps Trends" at GIIResearch.com

Researchers seek to develop novel antibody to treat glioblastoma

Scientists of Helmholtz Zentrum München and the Munich University Hospital are developing a novel antibody to treat brain tumors.

TUM scientists uncover novel mechanisms of action for skin disease medication

Imiquimod is a medication successfully used in the treatment of skin diseases. In addition to its known mechanism of action, it also triggers other processes in the body.

Scientists have captured on video the intracellular version of a postal delivery service

Reporting in the journal Biochemical and Biophysical Research Communications (BBRC), bioengineering researchers at UC San Diego published videos of a key message-carrying protein called paxillin moving abruptly from hubs of communication and transportation activity on the cell surface toward the nucleus.

Read more Medical News

› Verified 3 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center43
    Adult patient months included in Kt/V greater than or equal to 1.2327
    Percentage of adult patients getting regular hemodialysis at the center93
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Lawmakers, though still elbowing, agree on some health care reforms

    Lost in the debate over key issues is the fact that lawmakers working on health care reform agree on major parts of reform, The Los Angeles Times reports.

    New report analyzes Mobile Medical Apps market worldwide

    Global Information Inc. announces the addition of a new market research report "Mobile Medical Apps Trends" at GIIResearch.com

    Researchers seek to develop novel antibody to treat glioblastoma

    Scientists of Helmholtz Zentrum München and the Munich University Hospital are developing a novel antibody to treat brain tumors.

    TUM scientists uncover novel mechanisms of action for skin disease medication

    Imiquimod is a medication successfully used in the treatment of skin diseases. In addition to its known mechanism of action, it also triggers other processes in the body.

    Scientists have captured on video the intracellular version of a postal delivery service

    Reporting in the journal Biochemical and Biophysical Research Communications (BBRC), bioengineering researchers at UC San Diego published videos of a key message-carrying protein called paxillin moving abruptly from hubs of communication and transportation activity on the cell surface toward the nucleus.

    Read more Medical News

    › Verified 3 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita - Hilliard Station Dialysis with elevated calcium levels.

Patients with hypercalcemia45
Hypercalcemia patient months341
Hypercalcemia patients with serumcalcium greater than 10.2 mg1
Patients with Serumphosphor46
Patients with Serumphosphor less than 3.5 mg/dL6
Patients with Serumphosphor from 3.5 to 4.5 mg/dL29
Patients with Serumphosphor from 4.6 to 5.5 mg/dL38
Patients with Serumphosphor from 5.6 to 7 mg/dL19
Patients with Serumphosphor greater than 7 mg/dL8

News Archive

Lawmakers, though still elbowing, agree on some health care reforms

Lost in the debate over key issues is the fact that lawmakers working on health care reform agree on major parts of reform, The Los Angeles Times reports.

New report analyzes Mobile Medical Apps market worldwide

Global Information Inc. announces the addition of a new market research report "Mobile Medical Apps Trends" at GIIResearch.com

Researchers seek to develop novel antibody to treat glioblastoma

Scientists of Helmholtz Zentrum München and the Munich University Hospital are developing a novel antibody to treat brain tumors.

TUM scientists uncover novel mechanisms of action for skin disease medication

Imiquimod is a medication successfully used in the treatment of skin diseases. In addition to its known mechanism of action, it also triggers other processes in the body.

Scientists have captured on video the intracellular version of a postal delivery service

Reporting in the journal Biochemical and Biophysical Research Communications (BBRC), bioengineering researchers at UC San Diego published videos of a key message-carrying protein called paxillin moving abruptly from hubs of communication and transportation activity on the cell surface toward the nucleus.

Read more Medical News

› Verified 3 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 28
Patient months included in arterial venous fistula and catheter summaries 184
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment56
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer22

News Archive

Lawmakers, though still elbowing, agree on some health care reforms

Lost in the debate over key issues is the fact that lawmakers working on health care reform agree on major parts of reform, The Los Angeles Times reports.

New report analyzes Mobile Medical Apps market worldwide

Global Information Inc. announces the addition of a new market research report "Mobile Medical Apps Trends" at GIIResearch.com

Researchers seek to develop novel antibody to treat glioblastoma

Scientists of Helmholtz Zentrum München and the Munich University Hospital are developing a novel antibody to treat brain tumors.

TUM scientists uncover novel mechanisms of action for skin disease medication

Imiquimod is a medication successfully used in the treatment of skin diseases. In addition to its known mechanism of action, it also triggers other processes in the body.

Scientists have captured on video the intracellular version of a postal delivery service

Reporting in the journal Biochemical and Biophysical Research Communications (BBRC), bioengineering researchers at UC San Diego published videos of a key message-carrying protein called paxillin moving abruptly from hubs of communication and transportation activity on the cell surface toward the nucleus.

Read more Medical News

› Verified 3 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary21
Hospitalization Rate in facility164.7 (As Expected)
Hospitalization Rate: Upper Confidence Limit417.4
Hospitalization Rate: Lower Confidence Limit69.9

News Archive

Lawmakers, though still elbowing, agree on some health care reforms

Lost in the debate over key issues is the fact that lawmakers working on health care reform agree on major parts of reform, The Los Angeles Times reports.

New report analyzes Mobile Medical Apps market worldwide

Global Information Inc. announces the addition of a new market research report "Mobile Medical Apps Trends" at GIIResearch.com

Researchers seek to develop novel antibody to treat glioblastoma

Scientists of Helmholtz Zentrum München and the Munich University Hospital are developing a novel antibody to treat brain tumors.

TUM scientists uncover novel mechanisms of action for skin disease medication

Imiquimod is a medication successfully used in the treatment of skin diseases. In addition to its known mechanism of action, it also triggers other processes in the body.

Scientists have captured on video the intracellular version of a postal delivery service

Reporting in the journal Biochemical and Biophysical Research Communications (BBRC), bioengineering researchers at UC San Diego published videos of a key message-carrying protein called paxillin moving abruptly from hubs of communication and transportation activity on the cell surface toward the nucleus.

Read more Medical News

› Verified 3 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Davita - Hilliard Station Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility23.3 (As Expected)
Readmission Rate: Upper Confidence Limit40.1
Readmission Rate: Lower Confidence Limit10.4

News Archive

Lawmakers, though still elbowing, agree on some health care reforms

Lost in the debate over key issues is the fact that lawmakers working on health care reform agree on major parts of reform, The Los Angeles Times reports.

New report analyzes Mobile Medical Apps market worldwide

Global Information Inc. announces the addition of a new market research report "Mobile Medical Apps Trends" at GIIResearch.com

Researchers seek to develop novel antibody to treat glioblastoma

Scientists of Helmholtz Zentrum München and the Munich University Hospital are developing a novel antibody to treat brain tumors.

TUM scientists uncover novel mechanisms of action for skin disease medication

Imiquimod is a medication successfully used in the treatment of skin diseases. In addition to its known mechanism of action, it also triggers other processes in the body.

Scientists have captured on video the intracellular version of a postal delivery service

Reporting in the journal Biochemical and Biophysical Research Communications (BBRC), bioengineering researchers at UC San Diego published videos of a key message-carrying protein called paxillin moving abruptly from hubs of communication and transportation activity on the cell surface toward the nucleus.

Read more Medical News

› Verified 3 days ago

Infection Rate

Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Davita - Hilliard Station Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.

Standard Infection Summary Ratio(SIR) YearJanuary, 2016 - December, 2016
Infection Rate in facility1.6 (As Expected)
SIR: Upper Confidence Limit3.54
SIR: Lower Confidence Limit.59

News Archive

Lawmakers, though still elbowing, agree on some health care reforms

Lost in the debate over key issues is the fact that lawmakers working on health care reform agree on major parts of reform, The Los Angeles Times reports.

New report analyzes Mobile Medical Apps market worldwide

Global Information Inc. announces the addition of a new market research report "Mobile Medical Apps Trends" at GIIResearch.com

Researchers seek to develop novel antibody to treat glioblastoma

Scientists of Helmholtz Zentrum München and the Munich University Hospital are developing a novel antibody to treat brain tumors.

TUM scientists uncover novel mechanisms of action for skin disease medication

Imiquimod is a medication successfully used in the treatment of skin diseases. In addition to its known mechanism of action, it also triggers other processes in the body.

Scientists have captured on video the intracellular version of a postal delivery service

Reporting in the journal Biochemical and Biophysical Research Communications (BBRC), bioengineering researchers at UC San Diego published videos of a key message-carrying protein called paxillin moving abruptly from hubs of communication and transportation activity on the cell surface toward the nucleus.

Read more Medical News

› Verified 3 days ago

Transfusion Summary

Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita - Hilliard Station Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.

Standard Transfusion Summary Ratio (STrR) Year January, 2016 - December, 2016
Patients in facility's Transfusion Summary 18
Transfusion Rate in facility9 (As Expected)
Transfusion Rate: Upper Confidence Limit307.5
Transfusion Rate: Lower Confidence Limit.4

News Archive

Lawmakers, though still elbowing, agree on some health care reforms

Lost in the debate over key issues is the fact that lawmakers working on health care reform agree on major parts of reform, The Los Angeles Times reports.

New report analyzes Mobile Medical Apps market worldwide

Global Information Inc. announces the addition of a new market research report "Mobile Medical Apps Trends" at GIIResearch.com

Researchers seek to develop novel antibody to treat glioblastoma

Scientists of Helmholtz Zentrum München and the Munich University Hospital are developing a novel antibody to treat brain tumors.

TUM scientists uncover novel mechanisms of action for skin disease medication

Imiquimod is a medication successfully used in the treatment of skin diseases. In addition to its known mechanism of action, it also triggers other processes in the body.

Scientists have captured on video the intracellular version of a postal delivery service

Reporting in the journal Biochemical and Biophysical Research Communications (BBRC), bioengineering researchers at UC San Diego published videos of a key message-carrying protein called paxillin moving abruptly from hubs of communication and transportation activity on the cell surface toward the nucleus.

Read more Medical News

› Verified 3 days ago

Survival Summary

The rate of mortality show you whether patients who were being treated regularly at Davita - Hilliard Station Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.

Standard Survival Summary Ratio(SIR) YearJanuary, 2013 - December, 2016
Patients in facility's Survival Summary86
Mortality Rate in facility16.7 (As Expected)
Mortality Rate: Upper Confidence Limit31.7
Mortality Rate: Lower Confidence Limit7.6

News Archive

Lawmakers, though still elbowing, agree on some health care reforms

Lost in the debate over key issues is the fact that lawmakers working on health care reform agree on major parts of reform, The Los Angeles Times reports.

New report analyzes Mobile Medical Apps market worldwide

Global Information Inc. announces the addition of a new market research report "Mobile Medical Apps Trends" at GIIResearch.com

Researchers seek to develop novel antibody to treat glioblastoma

Scientists of Helmholtz Zentrum München and the Munich University Hospital are developing a novel antibody to treat brain tumors.

TUM scientists uncover novel mechanisms of action for skin disease medication

Imiquimod is a medication successfully used in the treatment of skin diseases. In addition to its known mechanism of action, it also triggers other processes in the body.

Scientists have captured on video the intracellular version of a postal delivery service

Reporting in the journal Biochemical and Biophysical Research Communications (BBRC), bioengineering researchers at UC San Diego published videos of a key message-carrying protein called paxillin moving abruptly from hubs of communication and transportation activity on the cell surface toward the nucleus.

Read more Medical News

› Verified 3 days ago


Dialysis Facility in Hilliard, OH

Davita - Hilliard Station Dialysis
Location: 2447 Hilliard Rome Road, Hilliard, Ohio, 43026
Phone: (614) 876-3610

News Archive

Lawmakers, though still elbowing, agree on some health care reforms

Lost in the debate over key issues is the fact that lawmakers working on health care reform agree on major parts of reform, The Los Angeles Times reports.

New report analyzes Mobile Medical Apps market worldwide

Global Information Inc. announces the addition of a new market research report "Mobile Medical Apps Trends" at GIIResearch.com

Researchers seek to develop novel antibody to treat glioblastoma

Scientists of Helmholtz Zentrum München and the Munich University Hospital are developing a novel antibody to treat brain tumors.

TUM scientists uncover novel mechanisms of action for skin disease medication

Imiquimod is a medication successfully used in the treatment of skin diseases. In addition to its known mechanism of action, it also triggers other processes in the body.

Scientists have captured on video the intracellular version of a postal delivery service

Reporting in the journal Biochemical and Biophysical Research Communications (BBRC), bioengineering researchers at UC San Diego published videos of a key message-carrying protein called paxillin moving abruptly from hubs of communication and transportation activity on the cell surface toward the nucleus.

Read more Medical News

› Verified 3 days ago


Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.